How Long Does a Parkinson's Clinical Trial Last?

If you've found a trial that looks like a good fit for your family member, one of the first practical questions is probably a simple one. How long is this actually going to take?

Why Trial Length Varies

Some trials are testing whether a treatment is safe over a short period. Others are trying to understand whether a treatment can slow Parkinson's progression over years.

Phase 1: Weeks to a Few Months

Phase 1 trials are focused on safety in a small group of participants. These tend to be the shortest.

Phase 2: A Few Months to About a Year

Phase 2 trials expand the participant pool and start measuring whether the treatment actually works.

Phase 3: One to Three Years or More

Phase 3 trials are the most demanding in terms of time. They're large, rigorous studies designed to confirm whether a treatment works better than what already exists.

Phase 4: Ongoing

Phase 4 trials involve treatments that are already FDA approved. The commitment level is often lighter than in Phase 3.

A Simple Way to Remember It

• Phase 1 — Weeks to a few months
• Phase 2 — A few months to about a year
• Phase 3 — One to three years or more
• Phase 4 — Ongoing, often lighter commitment